Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
Benjamin E Stubbe*, Poul H Madsen, Anders C Larsen, Henrik B Krarup, Inge S Pedersen, Carsten P Hansen, Julia S Johansen, Stine D Henriksen, Ole Thorlacius-Ussing
Dyk ned i forskningsemnerne om 'Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma'. Sammen danner de et unikt fingeraftryk.